Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant
Clinical Transplantation · 2024
DOI: 10.1111/ctr.70006 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Benjamin N Herrmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Basiliximab, Liver Transplantation, Recombinant Fusion Proteins, Graft Rejection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Basiliximab is a high‐cost induction agent typically given as two doses in liver transplant recipients. This study evaluated renal outcomes in live‐donor liver transplant recipients (LDLTRs) with stable renal function at the time of transplant receiving one versus two doses of basiliximab.
Methods
We retrospectively identified 231 adult LDLTR with a serum creatinine (SCr)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
- Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Benjamin N Herrmann
Zitieren
APA
Herrmann, B. N., Moore, C. A., Johnson, H. J., Humar, A., & Shimko, K. A. (2024). Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant. Clinical Transplantation. https://doi.org/10.1111/ctr.70006
Vancouver
Herrmann BN, Moore CA, Johnson HJ, Humar A, Shimko KA. Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant. Clinical Transplantation. 2024. doi:10.1111/ctr.70006
BibTeX
@article{Herrmann2024,
author = {Herrmann, Benjamin N and Moore, Cody A and Johnson, Heather J and Humar, Abhinav and Shimko, Kristen A},
title = {Evaluation of Single Versus Two‐Dose Basiliximab Induction Therapy in Live‐Donor Liver Transplant},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.70006}
}
EUVIMED